Benzinga's Top Upgrades

Analysts at SunTrust Robinson Humphrey upgraded Exelon Corporation EXC from Neutral to Buy. The price target for Exelon has been raised from $30 to $33. Exelon shares closed at $29.70 on Friday. Barrington Research upgraded USA Technologies, Inc. USAT to Outperform. USA Technologies shares closed at $2.88 on Friday. Analysts at KeyBanc upgraded Biomed Realty Trust Inc BMR to Overweight. BioMed Realty Trust shares closed at $18.91 on Friday. Citigroup upgraded Mack Cali Realty Corp CLI from Neutral to Buy. The price target for Mack-Cali Realty has been raised from $22 to $24. Mack-Cali Realty shares closed at $19.64 on Friday. Analysts at Deutsche Bank upgraded AstraZeneca plc (ADR) AZN from Hold to Buy. AstraZeneca shares closed at $33.30 on Friday. Analysts at Goldman Sachs upgraded Xilinx, Inc. XLNX from Neutral to Buy. The price target for Xilinx has been raised from $41 to $50. Xilinx shares closed at $41.93 on Friday. Analysts at Macquarie upgraded Oppenheimer Holdings Inc. (USA) OPY from Neutral to Outperform. The price target for Oppenheimer Holdings has been raised from $25 to $27. Oppenheimer Holdings shares closed at $17.98 on Friday. Barclays upgraded Vertex Pharmaceuticals Incorporated VRTX from Equal-weight to Overweight. The price target for Vertex Pharmaceuticals has been raised from $120 to $150. Vertex Pharmaceuticals shares closed at $134.06 on Friday. Citigroup upgraded Ingredion Inc INGR from Neutral to Buy. The price target for Ingredion has been raised from $90 to $100. Ingredion shares closed at $83.29 on Friday. KeyBanc upgraded Taubman Centers, Inc. TCO to Overweight. Taubman Centers shares closed at $68.26 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!